Axsome Therapeutics, Inc. (AXSM)
209.87
+7.04
(+3.47%)
USD |
NASDAQ |
Sep 02, 16:00
209.87
0.00 (0.00%)
After-Hours: 17:53
Axsome Therapeutics Cash and Short Term Investments (Quarterly) : 319.85M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 319.85M |
| March 31, 2026 | 305.11M |
| December 31, 2025 | 322.93M |
| September 30, 2025 | 325.27M |
| June 30, 2025 | 303.02M |
| March 31, 2025 | 300.91M |
| December 31, 2024 | 315.35M |
| September 30, 2024 | 327.34M |
| June 30, 2024 | 315.66M |
| March 31, 2024 | 331.44M |
| December 31, 2023 | 386.19M |
| September 30, 2023 | 416.56M |
| June 30, 2023 | 437.11M |
| March 31, 2023 | 246.52M |
| December 31, 2022 | 200.84M |
| September 30, 2022 | 227.52M |
| June 30, 2022 | 73.39M |
| March 31, 2022 | 84.71M |
| December 31, 2021 | 86.47M |
| September 30, 2021 | 114.62M |
| June 30, 2021 | 141.22M |
| March 31, 2021 | 164.66M |
| Date | Value |
|---|---|
| December 31, 2020 | 183.88M |
| September 30, 2020 | 202.36M |
| June 30, 2020 | 190.68M |
| March 31, 2020 | 197.31M |
| December 31, 2019 | 219.97M |
| September 30, 2019 | 43.64M |
| June 30, 2019 | 53.75M |
| March 31, 2019 | 42.62M |
| December 31, 2018 | 13.97M |
| September 30, 2018 | 15.22M |
| June 30, 2018 | 20.35M |
| March 31, 2018 | 26.63M |
| December 31, 2017 | 34.02M |
| September 30, 2017 | 31.67M |
| June 30, 2017 | 37.99M |
| March 31, 2017 | 45.02M |
| December 31, 2016 | 36.62M |
| September 30, 2016 | 33.89M |
| June 30, 2016 | 38.75M |
| March 31, 2016 | 44.08M |
| December 31, 2015 | 48.04M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Eli Lilly & Co. | 8.95B |
| Liquidia Corp. | 284.18M |
| Filana Therapeutics, Inc. | 82.68M |
| CorMedix, Inc. | 257.35M |
| Eloxx Pharmaceuticals, Inc. | 61.97M |